The Bioactive Coating Devices market size is projected to be valued at USD 307.45 Million in 2022 and is expected to rise to USD 695.13 Million by 2032. The demand for bioactive coating devices is expected to grow at a significant CAGR of 8.5% during the forecast period. Crucial factors propelling the market for bioactive coating devices are:
| Attributes | Details |
|---|---|
| Bioactive Coating Devices Market Value (2022) | USD 307.45 Million |
| Bioactive Coating Devices Market Forecast Value (2032) | USD 695.13 Million |
| Bioactive Coating Devices Market CAGR (2022 to 2032) | 8.5% |
Bioactive coatings are thin films coated on medical devices to deter bacterial adhesion, improve core functionality of the device and impart bioactivity along with biocompatibility to the device. This is more commonly used in implantable devices. Bioactive coatings include bio ceramics, extra cellular matrix proteins, biological peptides, growth factors and anti-microbial peptides with anti-microbial properties.
These coatings are largely being used in manufacturing of adequate implantable orthopedic prosthetic devices in order to reduce bacterial adhesion and prosthetic infections. Research is currently ongoing in development of other bioactive coatings containing nitric oxide, antibiotics and silver among others.
Developments in material science coupled with cell biology are important factors accelerating product penetration in the developed markets.
Medical coatings are majorly used in the healthcare facilities to modify the different planes of devices, medical equipment, and implants. Intense and regular use of medical devices has resulted in hostile factors, including wearing out, increase in infections, development of microbes and increase in friction and corrosion.
Thus bioactive coating medical devices are manufactured with the usage of microbial agents to counter these adverse effects. There are different types of coating according to the specifications required by the customers. Antimicrobial coatings are is majorly used to inhibit the growth of such micro-organisms on the surface of medical devices.
Lubricious coatings is used to lubricate the surface of medical devices to avoid rough texture, reduce the static and kinetic friction between two medical device surfaces which causes an easy insertion. The least used coating is optical coatings, which is used on optical devices to change their properties such as reflecting properties and clear visibility.
Increasing bioactive coating medical devices used for surgeries and medical device implants are the major driver of the bioactive coating devices market. Increasing costs of bioactive materials for coating and healthcare facilities is one of the inhibitor of the market.
The other factors like sterility testing, and expiration date of medical devices, also impacts the medical device industry. To increase the sale the medical device and coating manufacturers are focused on the regions where the regulatory approval processes and approval timelines are quick.
This made many USA based local manufacturer prefer to launch their products in the European region.
The growing number of hip and knee implant procedures among the obese and elderly population is expected to boost the revenue share of the bioactive coating devices industry during the forecast period. Furthermore, growing investment by leading market players to produce new and better technologically sophisticated products, as well as increased government spending to enhance healthcare infrastructure, is expected to boost industry share in the future years.
Bioactive coatings in implanted medical devices are being pushed forward by investments and research in specialized R&D in developed markets, growing academic interest in cell biology, and a greater emphasis on avoiding antimicrobial contamination to minimize antibiotic indiscriminate usage. Furthermore, the antimicrobial coatings sector may deliver significant gains to the bioactive coating device manufacturers throughout the study period.
Multiple manufacturers are shifting to produce antimicrobial coatings made up of compounds that prevent disease-causing bacteria from growing on a surface while also increasing corrosion resistance, durability, and attractiveness.
Furthermore, bioactive coating devices are gaining popularity due to their numerous advantages, including long-term disease protection, increased longevity, cost-effectiveness, enhanced health and cleanliness, and added infrastructure value.
On the other hand, stents are expected to show strong growth patterns in terms of product application, driven by the incidence of cardiovascular illnesses among the aging population. The bioactive coating on stents protects them from contamination and increases their durability, functioning, and life term, lowering the risk of corrective surgical treatments dramatically.
Due to the availability of modern equipment and qualified and certified medical staff, diagnostic centers may develop as a prominent end-use segment throughout the predicted timeframe. Furthermore, the growing need for better supervision and treatment, as well as enhanced healthcare infrastructure in these settings, are likely to promote revenue growth for key players.
Increased Medication Loading and Delivery to Aid in Unlocking New Opportunities
Implantable devices containing thin films of bioactive molecules are rapidly gaining momentum in the sectors of cardiology and orthopedic joint issues, which are now the two major causes of loss of quality of life and disability. To optimize medication loading and delivery, bioactive molecules are being used by bioactive coating device manufacturers to load and release a large number of material-bound components.
Rising Diseases to Boost the Demand
The increased prevalence of systemic joint disorders, cardiovascular implants, and support - all of which are a direct result of the world's rapidly aging population - are boosting the demand for bioactive coating devices.
Implantable devices containing thin films of bioactive molecules are rapidly gaining adoption in therapeutic areas of cardiology and orthopedic joint diseases - the two major sources of loss of quality of life and disability currently. Bioactive molecules are being used to load and release large number of material bound constituents for enhanced drug loading and delivery.
Generic factors such as increasing incidence of systemic joint diseases, cardiovascular implant and support - both a direct by-product of rapidly ageing global population are accelerating the demand for bioactive coating devices across the world.
Investments in niche R&D in developed markets, growing academic interest in cell biology, and greater focus on reduction of antimicrobial contamination in order to restrict indiscriminate usage of antibiotics - are factors promoting investments and research on bioactive coatings in implantable medical devices.
Barriers of bioactive coating devices market include high probability of loss of effectiveness of the bioactive coating when they come in contact with external physiological environment, finite reservoir of bioactive agents and less number of possible applications presently.
Other hurdles include lack of research awareness, high requirement for funding for continued research and less developed research infrastructure in middle and low income countries among others.
The global bioactive coating devicesmarket is expected to expand at healthy CAGR owing to increasing in the adoption of anti-microbial coatings medical device coatings market, of the products across the world. Among end users, hospital end user segment is expected to account for maximum share due to requirement of advanced healthcare infrastructure and surgical devices.
Geographically, the global bioactive coating devicesmarket is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. Among all the regions, North America will continue to lead the global market for bioactive coating devicesmarket due to high purchasing power.
Asia- Pacific is expected to account for second largest share in global market primarily due to low grade medical devices which gets effected by the high concentrated chemical , and adulteration in metals used in prepare the medical devices. Regional overview can be a directly proportional to the usage of medical devices.
Key players operating in the global bioactive coating devices market are DSM Biomedical, Hydromer Inc., SurModics Inc., Biocoat Inc., AST Products Inc., Specialty Coatings Systems Inc., and others
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies.
The research report provides analysis and information according to categories such as market segments, geographies, type of product and applications.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The global market for bioactive coating devicesis broadly classified on the basis of product type, by medical application, by material and by end user.
Explore Similar Insights
Bioactive Coating Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
